GILEAD SCIENCES, INC. Restructuring Reserve, Current
GILEAD SCIENCES, INC. (GILD) had Restructuring Reserve, Current of $60.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:RestructuringReserveCurrent · last filed 2026-08-06
- 2026-06-30: Restructuring Reserve, Current $60.00M.
- 2026-03-31: Restructuring Reserve, Current $73.00M.
- 2025-12-31: Restructuring Reserve, Current $61.00M.
- 2025-09-30: Restructuring Reserve, Current $52.00M.
| Period end | Restructuring Reserve, Current |
|---|---|
| 2026-06-30 | $60.00M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $73.00M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $61.00M 10-K · filed 2026-02-24 |
| 2025-09-30 | $52.00M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $92.00M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $138.00M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $93.00M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |